iiinova — where your digital self keeps evolving

JCF Intersections @jcfint.bsky.social · 13/10/2026

❤️‍🩹 Recovered EF doesn't tell the whole story. In HFrecEF, higher baseline LVEF predicted faster EF recovery, but paradoxically higher NT-proBNP🧪 at recovery. Could biomarkers help identify residual HF risk & opportunities to optimize GDMT? 🔗 bit.ly/3UZVYwM

000

JCF Intersections @jcfint.bsky.social · 12/10/2026

How does dyspnea evolve after HF hospitalization? In this longitudinal cohort study, over 6 months, 63% improved, 17% remained symptomatic & 19% worsened. Less favorable trajectories tracked with greater fatigue, sleep, pain, depression & anxiety. 💜 #HFSASimPub 🔗 bit.ly/4yLFAPm

000

JCF Intersections @jcfint.bsky.social · 11/10/2026

🔎 Could wtATTR-CA be recognized years earlier? In 182 patients, extracardiac manifestations🩻 were nearly universal. CTS, spinal stenosis & trigger finger were common, with related surgeries occurring 7–10 years before cardiac diagnosis. #HFSASimPub 🔗 bit.ly/4ye1EkA

000

JCF Intersections @jcfint.bsky.social · 06/10/2026

Heart failure doesn't pause for pregnancy🤰, but many HF medications do. 💊🫀 This State-of-the-Art review provides a practical guide to GDMT across preconception, pregnancy, postpartum & lactation ... balancing maternal health with fetal safety. 🤱 🔗 bit.ly/4gVwGIK

000

JCF Intersections @jcfint.bsky.social · 30/09/2026

💪 What if time on temporary MCS wasn't just spent waiting for LVAD or transplant, but preparing for it? This Teachable Moments article explores “prehabilitation”: building physical, psychological & emotional readiness for advanced HF therapies. 🫀 🔗 bit.ly/4j7kCFJ

000

JCF Intersections @jcfint.bsky.social · 24/09/2026

🤔 How should we assess congestive hepatopathy in advanced HF? Conventional liver tests can be misleading. This State-of-the-Art review explores multimodality assessment, including biopsy & HVPG, and individualized heart vs heart-liver transplant decisions. 🔗 bit.ly/4h0LNPK

001

JCF Intersections @jcfint.bsky.social · 22/09/2026

📝Editorial perspective: Is less sedation always better in the CICU? Deep sedation may offer physiologic benefits in selected cardiac patients, including afterload reduction & arrhythmia control. Maybe the question is: Who needs deeper sedation, and when? 🔗 bit.ly/4dHsKJs

000

JCF Intersections @jcfint.bsky.social · 22/09/2026

🚨New Science alert! 💻 Can an EHR nudge reduce deep sedation in the CICU? A clinical decision-support tool reduced early deep sedation😴 by ~6 hours in the CICU. But without improvement in ventilation duration, ICU stay, tracheostomy, or survival. 🔗 bit.ly/4j5DzbM

100

JCF Intersections @jcfint.bsky.social · 16/09/2026

Stay curious this September. 🫀 The latest issue of JCF-I is out now, with new perspectives and conversations designed to challenge thinking, encourage learning, and connect the heart failure community. See what’s new: www.onlinejcfi.org/current #JCFIntersections #HeartFailure #Cardiology

000

JCF Intersections @jcfint.bsky.social · 01/09/2026

At JCF-Intersections, we believe in collaborative research looking at the intersections of heart failure and medical care. Let's work together to advance patient care! www.onlinejcfi.org #Cardiology #HeartFailure

000

JCF Intersections @jcfint.bsky.social · 27/08/2026

Already reviewed, but rejected? 💡 Don’t waste the effort. Submit to JCF-I Express: Court of Appeals for expedited review based on prior peer feedback from a non-JCF Journal. ✅ No momentum lost 👉 hfsa.org/jcf-express-court-appeals

000

JCF Intersections @jcfint.bsky.social · 18/08/2026

Submitting to JCF-Intersections? No need to format perfectly at first! Our Your Paper Your Way policy lets you submit in any format. Format later—focus on the research now. 💡 www.onlinejcfi.org

000

JCF Intersections @jcfint.bsky.social · 12/08/2026

Your research deserves a second chance—without starting from scratch. If your cardiology manuscript underwent detailed peer review but wasn’t accepted at a non-JCF journal, submit it to JCF-I Express: Court of Appeals. 🔗👇

110

JCF Intersections @jcfint.bsky.social · 06/08/2026

Stay up to date with the latest research on the intersections of cardiovascular care. Follow JCF-Intersections for cutting-edge research and insights. #Cardiology #HeartFailure

000

JCF Intersections @jcfint.bsky.social · 04/08/2026

🫀🏥 How would you reimagine the CICU? This Perspectives article envisions a data-driven, human-centered CICU built on 3 pillars: clinical care, research & quality improvement, and education, leveraging AI and predictive analytics to deliver smarter care. 🔗 www.onlinejcfi.org/article/S305...

000

JCF Intersections @jcfint.bsky.social · 29/07/2026

New science 🚨! Which HCM patients are most likely to develop LV systolic dysfunction on mavacamten?🫀 LBBB, ventricular pacing, AF & greater LGE burden were associated with risk. Most events occurred within 12 weeks of initiation or dose escalation. 📊 🔗 www.onlinejcfi.org/article/S305...

000

JCF Intersections @jcfint.bsky.social · 28/07/2026

📝 Editorial perspective HF is rising, but access to advanced HF expertise remains uneven. Expanding the AHFTC pipeline & developing innovative care models will be critical to improving access in underserved regions. 🫀 🔗 bit.ly/4bjddhV

000

JCF Intersections @jcfint.bsky.social · 28/07/2026

🫀Where are the nation's AHFTC specialists? This study identified only 1,523 AHFTCs in the US, w/ marked geographic disparities. Workforce density was highest in regions w/ greater transplant activity, fellowship training & cardiology infrastructure. 🔗 bit.ly/4yRSXhF

100

JCF Intersections @jcfint.bsky.social · 23/07/2026

📝 Editorial perspective Is it time to rethink routine fluid restriction in HF? Modern GDMT has transformed care, yet fluid limits remain common. These findings support a more individualized, evidence-informed approach. 💧🫀 🔗 bit.ly/3TeyC5L

000

JCF Intersections @jcfint.bsky.social · 23/07/2026

New science🚨! Does fluid restriction improve outcomes in chronic HF?💧 This meta-analysis of 9 RCTs (1,335 pts) found no significant differences in mortality, HFH, congestion, biomarkers or QoL between restrictive & liberal fluid strategies. 🔗 bit.ly/4gYZdxD

100

JCF Intersections @jcfint.bsky.social · 21/07/2026

📝 How should we measure physical activity in pediatric HCM? This editorial argues that better tools are needed as we move toward shared decision-making. Wearables, questionnaires & exercise testing all have limitations; but measuring activity accurately is essential. 🔗 bit.ly/45fWhW4

000

JCF Intersections @jcfint.bsky.social · 21/07/2026

🏃Children with HCM are far less active than recommended. In this multicenter 🇨🇦 study, only 12.5% achieved daily activity targets & ~4% reported regular moderate-to-vigorous exercise. We need better guidance that balances safety & lifelong🫀health. 🔗 bit.ly/4fd50yd

100

JCF Intersections @jcfint.bsky.social · 15/07/2026

🫀The July issue of Journal of Cardiac Failure - Intersections is now available! 👉 Get the latest perspectives and conversations in heart failure and its various intersections. Read the full issue 📖 www.onlinejcfi.org/current

000

JCF Intersections @jcfint.bsky.social · 14/07/2026

JCF-Intersections invites submissions spanning original investigations, state-of-the-art reviews, and patient narratives. Join us in advancing multidisciplinary care. Information for Authors: bit.ly/40hRwt7 #Cardiology #HeartFailure

000

JCF Intersections @jcfint.bsky.social · 08/07/2026

Researchers: Have you invested time in a full peer review only to face rejection? Your next step is JCF-I Express: Court of Appeals. You can resubmit previously reviewed manuscripts (outside JCF), include prior reviews, and skip repeating the full process. 🔗 Learn more: bit.ly/4fV1nOi

000

JCF Intersections @jcfint.bsky.social · 24/06/2026

Palliative inotropes can improve comfort & QOL for patients with advanced HF in hospice. But access remains challenging. This Perspectives piece shares a practical roadmap: engage stakeholders, educate teams, build workflows & navigate real-world barriers. 🤝🫀 🔗 bit.ly/43Do8P8

000

JCF Intersections @jcfint.bsky.social · 10/06/2026

When severe functional MR complicates advanced HF, M-TEER is not always the destination; it may be the bridge. This "Teachable Moment"📖 explores functional MR, timing of intervention, & how valve repair fits alongside LVAD/transplant decision-making. 🫀 🔗 bit.ly/4vhlQBg

000

JCF Intersections @jcfint.bsky.social · 09/06/2026

Where you live influences HF risk. In >1,900 U.S. counties, higher social vulnerability & deprivation were independently associated with more HF hospitalizations, reinforcing that social determinants are central to HF outcomes. 📍🫀 Social risk ➡️ HF risk 🔗 bit.ly/4u1AY4o

000

JCF Intersections @jcfint.bsky.social · 04/06/2026

HF is now the leading cause of death in adults with congenital heart disease. ❤️‍🩹 This 🔥State-of-the-Art review highlights why ACHD-HF differs from acquired HF: heterogeneous anatomy, limited GDMT data, and growing interest in ARNI/SGLT2i therapy. 🫀 🔗 bit.ly/43DnQru

000

JCF Intersections @jcfint.bsky.social · 02/06/2026

Anthracycline cardiotoxicity remains a major challenge in cardio-oncology. This meta-analysis suggests SGLT2i may reduce mortality, HF events, & arrhythmias in anthracycline-treated patients, with reassuring safety signals. A promising prevention strategy? 🫀 🔗 bit.ly/4o2aGOs

000

JCF Intersections @jcfint.bsky.social · 26/05/2026

New month. New conversations in heart failure. The May issue of JCF-Intersections is out now featuring fresh insights, expert perspectives, and meaningful discussion from across the field. www.onlinejcfi.org/current

000

JCF Intersections @jcfint.bsky.social · 30/04/2026

Should cardiogenic shock teams become the standard of care? It's up for debate!🫀 One viewpoint argues yes: multidisciplinary shock teams can streamline diagnosis, coordinate care & improve outcomes across institutions. Observational data support their impact. 🔗 bit.ly/4t53Okt

100

JCF Intersections @jcfint.bsky.social · 28/04/2026

tMCS (e.g., VA-ECMO) can save lives—but what if there’s no path forward? A new perspective examines the ethical challenge of the “bridge to nowhere” and explores concepts like dynamic consent, moral distress, distributive justice, and so much more!⚖️🫀 🔗 bit.ly/41oRsrt

000

JCF Intersections @jcfint.bsky.social · 21/04/2026

Percutaneous ECMO cannulation is life-saving, but high stakes. ‼️ An international Delphi consensus identified 77 core psychomotor skills across ECMO procedures, creating a framework for standardized training, competency assessment, and safer ECMO care. 🫀⚙️ 🔗 bit.ly/4d81410

000

JCF Intersections @jcfint.bsky.social · 15/04/2026

LVAD offers a stable platform to help patients overcome barriers to heart transplant. In one cohort, ~70% had modifiable barriers and 60% of these resolved at least one after LVAD, highlighting the role of multidisciplinary care.🫀📊 🔗 bit.ly/4uPEHUy

000

JCF Intersections @jcfint.bsky.social · 09/04/2026

Cardiogenic shock → low CO & end-organ hypoperfusion. LV failure is common, but don’t miss other causes: valvular disease, mechanical MI complications, or RV failure. A systematic approach + bedside echo can rapidly guide diagnosis and escalation.🫀 🔗 bit.ly/4uPBSTs

000

JCF Intersections @jcfint.bsky.social · 18/03/2026

JCF Intersections is out now! Where research meets perspective, and new ideas take shape across disciplines. Explore the latest 👉 www.onlinejcfi.org/current #HeartFailure #Cardiology

001

JCF Intersections @jcfint.bsky.social · 05/03/2026

Collaboration between HF clinicians, investigators, entrepreneurs & investors is key to solving unmet needs. Venture-backed innovation has driven advances from meds to devices, permitting HF cardiologists to shape patient-centric diagnostics & therapies. 🔗 bit.ly/4qX4KWU

000

JCF Intersections @jcfint.bsky.social · 03/03/2026

An 🛜 online, asynchronous curriculum improved critical-care trainees’ knowledge📚 of MCS devices, beyond what clinical exposure alone provided. Gains were strongest for LVAD management. Next step is assessing knowledge transfer into clinical setting🏥. 🔗 bit.ly/3NWnF5Z

010

JCF Intersections @jcfint.bsky.social · 26/02/2026

New science 🚨! In pts on pV-A ECMO, 20% developed de novo AF ❤️‍🩹. dnAF was linked to longer ECMO duration (6.4 vs 3.6 days) & ⬆️post-decannulation in-hospital mortality (33% vs 20%). PADP elevation trended toward ⬆️dnAF risk. 🔗 bit.ly/4r5dkTx

000

JCF Intersections @jcfint.bsky.social · 17/02/2026

Analyzing HFrEF & HFmrEF pts from the TriNetX cohort, metoprolol succinate was associated with ⬆️ event-free survival than tartrate, driven by ⬇️ hospitalizations & deaths. Results support guideline preference for succinate due to more consistent β1 blockade. 🔗 bit.ly/4jO2oau

000

JCF Intersections @jcfint.bsky.social · 11/02/2026

A HFrEF polypill💊 could ⬆️ GDMT uptake, but prescriber prefs are unknown. Using a 5-stage mixed-methods process, researchers built a discrete choice experiment to test cardiologists’ prefs—work that will directly inform future HFrEF polypill clinical trials. 🔗 bit.ly/3ZmjsLp

000

JCF Intersections @jcfint.bsky.social · 03/02/2026

New science 🚨! In an analysis of centrifugal-flow LVAD trials, digoxin💊 users showed greater improvement in 6MWT 🚶 vs no digoxin (especially in older pts) with similar QOL & AE rates. Digoxin was also linked to better 4-yr survival in NICM pts. 🔗 bit.ly/4r5phsy

000

JCF Intersections @jcfint.bsky.social · 27/01/2026

📣 Last chance to sign up for Office Hours! Join Editor in Chief Dr. Katz and Deputy Editor Dr. Reza to answer your questions on: ✅ JCF-I's upcoming publications ✅ What they are looking for in submissions ✅ Updates on the year ahead 📆 Wednesday, January 28th 🕐 12:00PM - 1:00PM 🔗 bit.ly/3NmOKz4

000

JCF Intersections @jcfint.bsky.social · 22/01/2026

The January issue of JCF-I is now available 👉 bringing forward new evidence, perspectives, and conversations in heart failure + various intersections. Read the full issue 📖 www.onlinejcfi.org/current

000

JCF Intersections @jcfint.bsky.social · 21/01/2026

Time is running out! Register for JCF-I Office Hours⌛ Join Editor in Chief Dr. Katz and Deputy Editor Dr. Reza to answer your questions on: ✅ JCF-I's upcoming publications ✅ What they are looking for in submissions ✅ Updates on the year ahead bit.ly/3NmOKz4

000

JCF Intersections @jcfint.bsky.social · 15/01/2026

🚨 JCF-I Office Hours Join Editor in Chief Dr. Katz and Deputy Editor Dr. Reza to answer your questions on: ✅ JCF-I's upcoming publications ✅ What they are looking for in submissions ✅ Updates on the year ahead 📆 Wednesday, January 28th 🕐 12:00PM - 1:00PM Register 🔗: bit.ly/3NmOKz4

000

JCF Intersections @jcfint.bsky.social · 17/12/2025

📢 New study in JCF-I on the safety and effectiveness of a low-carbohydrate ketogenic diet LCKD for weight loss in patients with overweight/obesity and HF. This is one of the largest real-world looks at LCKD use in HF. 🫀🍽️ See below ⬇️ bit.ly/3Ka9yZz

100

JCF Intersections @jcfint.bsky.social · 16/12/2025

How well can the right ventricle rise to the challenge? 💪💙 A new JCF-Intersections paper reviews right ventricular reserve (RVR) — the RV’s ability to boost output under stress. 🧵

100

JCF Intersections @jcfint.bsky.social · 03/12/2025

💡 CABG or PCI? A new perspective on value in ischemic cardiomyopathy. New #JCFIntersections study on cost-effectiveness analysis comparing CABG + OMT vs PCI + OMT is here. 🔗 Read in Journal of Cardiac Failure – Intersections: bit.ly/48oKsze #HeartFailure

100